These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37365756)

  • 1. Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined docking and molecular dynamics simulations approach.
    Alam A; Khan MS; Mathur Y; Sulaimani MN; Farooqui N; Ahmad SF; Nadeem A; Yadav DK; Mohammad T
    J Biomol Struct Dyn; 2024 Jul; 42(11):5758-5769. PubMed ID: 37365756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer.
    Nam KH; Yi SA; Nam G; Noh JS; Park JW; Lee MG; Park JH; Oh H; Lee J; Lee KR; Park HJ; Lee J; Han JW
    BMC Cancer; 2019 Aug; 19(1):773. PubMed ID: 31387554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of pharmacophore hypothesis, genetic function approximation model, and molecular docking to identify novel inhibitors of S6K1.
    Zhang H; Xiang ML; Liang JY; Zeng T; Zhang XN; Zhang J; Yang SY
    Mol Divers; 2013 Nov; 17(4):767-72. PubMed ID: 23982212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel S6K1 inhibitors by an ensemble-based virtual screening method and molecular dynamics simulation.
    Zhang H; Zhang HR; Zhang J; Hu ML; Ren L; Luo QQ; Qi HZ
    J Mol Model; 2023 Mar; 29(4):102. PubMed ID: 36933164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).
    Pearce LR; Alton GR; Richter DT; Kath JC; Lingardo L; Chapman J; Hwang C; Alessi DR
    Biochem J; 2010 Oct; 431(2):245-55. PubMed ID: 20704563
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Alshehri SA; Wahab S; Almoyad MAA
    J Biomol Struct Dyn; 2024 Nov; 42(18):9463-9474. PubMed ID: 37643015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of promising B lymphocyte kinase inhibitors using structure-guided virtual screening.
    Yang S; Wahab S; Almoyad MAA; Chen Y; Kalam N; Khalid M
    J Biomol Struct Dyn; 2024 Aug; 42(13):7054-7064. PubMed ID: 37688373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of organometallic S6K1 inhibitors.
    Qin J; Rajaratnam R; Feng L; Salami J; Barber-Rotenberg JS; Domsic J; Reyes-Uribe P; Liu H; Dang W; Berger SL; Villanueva J; Meggers E; Marmorstein R
    J Med Chem; 2015 Jan; 58(1):305-14. PubMed ID: 25356520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A virtual screening investigation to identify bioactive natural compounds as potential inhibitors of cyclin-dependent kinase 9.
    Atiya A; Shahidi H; Mohammad T; Sharaf SE; Abdulmonem WA; Ashraf GM; Elasbali AM; Alharethi SH; Alhumaydhi FA; Baeesa SS; Rehan M; Shamsi A; Shahwan M
    J Biomol Struct Dyn; 2023 Nov; 41(19):10202-10213. PubMed ID: 36562191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of the S6K1 kinase domain in complexes with inhibitors.
    Niwa H; Mikuni J; Sasaki S; Tomabechi Y; Honda K; Ikeda M; Ohsawa N; Wakiyama M; Handa N; Shirouzu M; Honma T; Tanaka A; Yokoyama S
    J Struct Funct Genomics; 2014 Sep; 15(3):153-64. PubMed ID: 25078151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy.
    Hassan MI; Anjum D; Mohammad T; Alam M; Khan MS; Shahwan M; Shamsi A; Yadav DK
    J Biomol Struct Dyn; 2023 Dec; 41(20):10558-10568. PubMed ID: 36495308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of high-affinity pyridoxal kinase inhibitors targeting cancer therapy: an integrated docking and molecular dynamics simulation approach.
    Banerjee P; Chandra A; Mohammad T; Singh N; Hassan MI; Qamar I
    J Biomol Struct Dyn; 2024 Oct; 42(16):8523-8540. PubMed ID: 37578056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new tool to dissect the function of p70 S6 kinase.
    Bilanges B; Vanhaesebroeck B
    Biochem J; 2010 Oct; 431(2):e1-3. PubMed ID: 20874709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protein kinase A inhibitor H-89 blocks polyploidization of SP600125-induced CMK cells by regulating phosphorylation of ribosomal protein S6 kinase 1].
    Zhao S; Yang J; Li C; Xing S; Yu Y; Liu S; Pu F; Ma D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1321-1326. PubMed ID: 27667455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of p70 S6 kinase (S6K1) activity by A77 1726 and its effect on cell proliferation and cell cycle progress.
    Doscas ME; Williamson AJ; Usha L; Bogachkov Y; Rao GS; Xiao F; Wang Y; Ruby C; Kaufman H; Zhou J; Williams JW; Li Y; Xu X
    Neoplasia; 2014 Oct; 16(10):824-34. PubMed ID: 25379019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of plant-based hexokinase 2 inhibitors: combined molecular docking and dynamics simulation studies.
    Khan A; Mohammad T; Shamsi A; Hussain A; Alajmi MF; Husain SA; Iqbal MA; Hassan MI
    J Biomol Struct Dyn; 2022; 40(20):10319-10331. PubMed ID: 34176437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p70 S6K1 nuclear localization depends on its mTOR-mediated phosphorylation at T389, but not on its kinase activity towards S6.
    Rosner M; Schipany K; Hengstschläger M
    Amino Acids; 2012 Jun; 42(6):2251-6. PubMed ID: 21710263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel FAK and S6K1 dual inhibitors from natural compounds via ADMET screening and molecular docking.
    Thiyagarajan V; Lin SH; Chang YC; Weng CF
    Biomed Pharmacother; 2016 May; 80():52-62. PubMed ID: 27133039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential inhibitors of tropomyosin receptor kinase B targeting CNS-related disorders and cancers.
    Hakami MA; Alotaibi BS; Hazazi A; Shafie A; Alsaiari AA; Ashour AA; Anjum F
    J Biomol Struct Dyn; 2024 Apr; 42(6):2965-2975. PubMed ID: 37184150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.